CRP and myocardial infarction: Rallidis et al. measured levels in patients presenting for severe UA or NSTEMI and demonstrated that sVCAM-1 was significantly elevated at presentation in those who later experienced major adverse cardiac events (death, nonfatal acute myocardial infarction, and recurrence of angina) during their hospitalization, which was independent of CRP level or classic risk factors [49].